The 12 Hallmarks of Aging in Dogs, Explained
Read full insightNAD+ for Dogs
By La Petite Labs Editorial 20 min read
References
Numbered references identify the sources used for specific claims. Read the study design, species and evidence boundaries alongside each finding.
-
Ratajczak J, Joffraud M, Trammell SA, et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Study design/context: Mechanistic studySpecies/context: mouse, mammalian cellsEvidence boundary: Experimental pathway work; not canine or feline absorption, dosing, or clinical efficacy.↩ 1 · ↩ 2 · ↩ 3 · ↩ 4 · ↩ 5 · ↩ 6
-
Kory N, Uit de Bos J, van der Rijt S, et al. MCART1/SLC25A51 is required for mitochondrial NAD transport. Study design/context: Mechanistic studySpecies/context: human cellsEvidence boundary: Intracellular transport mechanism; no oral precursor trial in dogs or cats.↩ 1 · ↩ 2
-
Simon KE, Russell K, Mondino A, et al. A randomized, controlled clinical trial demonstrates improved owner-assessed cognitive function in senior dogs receiving a senolytic and NAD+ precursor combination. Study design/context: Randomized controlled clinical trialSpecies/context: dogEvidence boundary: Combination-specific owner-assessed cognition result; does not isolate NR or establish efficacy of another formula.↩ 1 · ↩ 2 · ↩ 3 · ↩ 4 · ↩ 5
-
Cardoso D, Barthélémy I, Blot S, et al. Replenishing NAD+ content reduces aspects of striated muscle disease in a dog model of Duchenne muscular dystrophy. Study design/context: Muscular dystrophy disease-model experimentSpecies/context: dogEvidence boundary: Dogs with inherited muscular dystrophy received NAM, not NR. Not healthy senior-dog or feline evidence.↩ 1 · ↩ 2 · ↩ 3 · ↩ 4 · ↩ 5
-
You Y, Gao Y, Wang H, et al. Subacute Toxicity Study of Nicotinamide Mononucleotide via Oral Administration. Study design/context: Subacute oral toxicology studySpecies/context: dog, mouseEvidence boundary: Beagle exposure lasted 14 days and mild creatinine/uric-acid increases were reported. Not NR or long-term efficacy evidence.↩
-
Marinescu AG, Chen J, Holmes HE, et al. Safety Assessment of High-Purity, Synthetic Nicotinamide Riboside (NR-E) in a 90-Day Repeated Dose Oral Toxicity Study, With a 28-Day Recovery Arm. Study design/context: 90-day oral toxicology study with recovery armSpecies/context: ratEvidence boundary: Sprague-Dawley rats, not dogs or cats. Rat toxicology cannot establish long-term pet safety or a pet serving.↩
-
Zeng M, Zhou T, Li Z, et al. Transcriptomic and intervention evidence reveals domestic dogs as a promising model for anti-inflammatory investigation. Study design/context: Exploratory canine biomarker study with separate intervention arms and before-and-after comparisonsSpecies/context: dogEvidence boundary: Small NMN biomarker arm without an untreated placebo group; does not establish NR effects, clinical benefit or lifespan extension.↩ 1 · ↩ 2 · ↩ 3
-
G C Mills. Hemoglobin catabolism. I. Glutathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown. Study design/context: Biochemical mechanism experimentEvidence boundary: Biochemical erythrocyte experiment; no oral product effect inferred↩
-
Cristina Cerqua, Alberto Casarin, Fabien Pierrel, Luis Vazquez Fonseca, Giampiero Viola, Leonardo Salviati, Eva Trevisson. Vitamin K2 cannot substitute Coenzyme Q10 as electron carrier in the mitochondrial respiratory chain of mammalian cells. Study design/context: Cell experimentsSpecies/context: human cells, yeastEvidence boundary: Human-cell/yeast deficiency experiments; no canine supplement benefit inferred↩
-
U.S. Food and Drug Administration. “Complete and Balanced” Pet Food. Study design/context: Official guidanceSpecies/context: dogs, catsEvidence boundary: Nutritional adequacy labeling; does not establish whether an NAD+ supplement benefits dogs.↩
-
American Animal Hospital Association. Evaluating the Healthy Senior Pet. Study design/context: Official guidanceSpecies/context: dogs, catsEvidence boundary: Professional senior-care guidance about history and observation; not an NAD+ efficacy trial.↩ 1 · ↩ 2
Keep exploring
What would you like to understand next?
Search practical guides about healthy aging, cellular energy, ingredients, and daily support for dogs.

